MTND2P8

Across TCGA pan-cancer cohorts, MTND2P8 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MTND2P8 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MTND2P8 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND2P8 expression acts as an unfavorable survival marker, although some lineages such as READ and LGG show a favorable association.

UCEC, KIRC, and THYM are the cancer types where MTND2P8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	III,IV	0.274	0.629	.003	102	view →
KIRC	DFS	Tertile	II,III,IV	0.174	0.515	.024	24	view →
THYM	OS	Tertile	All	0.381	0.879	.003	24	view →
UCS	DFS	Tertile	All	0.136	0.523	.034	18	view →
READ	DFS	Tertile	All	1.000	0.466	.034	9	view →
STAD	OS	Quartile	IV	0.111	0.405	.008	3	view →
LGG	DFS	Tertile	All	0.886	0.352	.012	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MTND2P8–UCEC (DFS)

Open the UCEC breakdown →